Protein Description

Gene Symbol CHRM3
Entrez ID 1131
Uniprot ID P20309
Description cholinergic receptor, muscarinic 3
Chromosomal Location chr1: 239,386,565-239,915,452
Ontology GO ID GO Term Definition Evidence

BP

GO:0003056

regulation of vascular smooth muscle contraction

Any process that increases the frequency, rate or extent of vascular smooth muscle contraction.

IBA

BP

GO:0006464

cellular protein modification process

The covalent alteration of one or more amino acids occurring in proteins, peptides and nascent polypeptides (co-translational, post-translational modifications) occurring at the level of an individual cell. Includes the modification of charged tRNAs that are destined to occur in a protein (pre-translation modification).

TAS

BP

GO:0006939

smooth muscle contraction

A process in which force is generated within smooth muscle tissue, resulting in a change in muscle geometry. Force generation involves a chemo-mechanical energy conversion step that is carried out by the actin/myosin complex activity, which generates force through ATP hydrolysis. Smooth muscle differs from striated muscle in the much higher actin/myosin ratio, the absence of conspicuous sarcomeres and the ability to contract to a much smaller fraction of its resting length.

IEA

BP

GO:0007165

signal transduction

The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.

TAS

BP

GO:0007186

G-protein coupled receptor signaling pathway

A series of molecular signals that proceeds with an activated receptor promoting the exchange of GDP for GTP on the alpha-subunit of an associated heterotrimeric G-protein complex. The GTP-bound activated alpha-G-protein then dissociates from the beta- and gamma-subunits to further transmit the signal within the cell. The pathway begins with receptor-ligand interaction, or for basal GPCR signaling the pathway begins with the receptor activating its G protein in the absence of an agonist, and ends with regulation of a downstream cellular process, e.g. transcription. The pathway can start from the plasma membrane, Golgi or nuclear membrane (PMID:24568158 and PMID:16902576).

TAS

BP

GO:0007197

adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway

The series of molecular signals generated as a consequence of a G-protein coupled acetylcholine receptor binding to its physiological ligand, where the pathway proceeds with inhibition of adenylyl cyclase and a subsequent decrease in the concentration of cyclic AMP (cAMP).

IBA

BP

GO:0007207

phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway

The series of molecular signals generated as a consequence of a G-protein coupled acetylcholine receptor binding to its physiological ligand, where the pathway proceeds with activation of phospholipase C (PLC) and a subsequent release of inositol trisphosphate (IP3) and diacylglycerol (DAG).

IBA

BP

GO:0007213

G-protein coupled acetylcholine receptor signaling pathway

Any series of molecular signals initiated by an acetylcholine receptor on the surface of the target cell binding to one of its physiological ligands, and proceeding with the activated receptor promoting the exchange of GDP for GTP on the alpha-subunit of an associated heterotrimeric G-protein complex. The GTP-bound activated alpha-G-protein then dissociates from the beta- and gamma-subunits to further transmit the signal within the cell. The pathway begins with receptor-ligand interaction and ends with regulation of a downstream cellular process, e.g. transcription.

ISS

BP

GO:0007271

synaptic transmission, cholinergic

The process of communication from a neuron to a target (neuron, muscle, or secretory cell) across a synapse using the neurotransmitter acetylcholine.

IBA

BP

GO:0007399

nervous system development

The process whose specific outcome is the progression of nervous tissue over time, from its formation to its mature state.

TAS

BP

GO:0008283

cell proliferation

The multiplication or reproduction of cells, resulting in the expansion of a cell population.

TAS

BP

GO:0045987

positive regulation of smooth muscle contraction

Any process that activates or increases the frequency, rate or extent of smooth muscle contraction.

IEA

BP

GO:0046541

saliva secretion

The regulated release of saliva from the salivary glands. In man, the saliva is a turbid and slightly viscous fluid, generally of an alkaline reaction, and is secreted by the parotid, submaxillary, and sublingual glands. In the mouth the saliva is mixed with the secretion from the buccal glands. In man and many animals, saliva is an important digestive fluid on account of the presence of the peculiar enzyme, ptyalin.

IEA

CC

GO:0005886

plasma membrane

The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

TAS

CC

GO:0005887

integral component of plasma membrane

The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.

ISS

CC

GO:0016323

basolateral plasma membrane

The region of the plasma membrane that includes the basal end and sides of the cell. Often used in reference to animal polarized epithelial membranes, where the basal membrane is the part attached to the extracellular matrix, or in plant cells, where the basal membrane is defined with respect to the zygotic axis.

IEA

CC

GO:0030054

cell junction

A cellular component that forms a specialized region of connection between two or more cells or between a cell and the extracellular matrix. At a cell junction, anchoring proteins extend through the plasma membrane to link cytoskeletal proteins in one cell to cytoskeletal proteins in neighboring cells or to proteins in the extracellular matrix.

IEA

CC

GO:0030425

dendrite

A neuron projection that has a short, tapering, often branched, morphology, receives and integrates signals from other neurons or from sensory stimuli, and conducts a nerve impulse towards the axon or the cell body. In most neurons, the impulse is conveyed from dendrites to axon via the cell body, but in some types of unipolar neuron, the impulse does not travel via the cell body.

IEA

CC

GO:0032279

asymmetric synapse

A type of synapse occurring between an axon and a dendritic spine or dendritic shaft. Asymmetric synapses, the most abundant synapse type in the central nervous system, involve axons that contain predominantly spherical vesicles and contain a thickened postsynaptic density. Most or all synapses of this type are excitatory.

IEA

CC

GO:0043679

axon terminus

Terminal inflated portion of the axon, containing the specialized apparatus necessary to release neurotransmitters. The axon terminus is considered to be the whole region of thickening and the terminal button is a specialized region of it.

IEA

CC

GO:0045202

synapse

The junction between a nerve fiber of one neuron and another neuron or muscle fiber or glial cell; the site of interneuronal communication. As the nerve fiber approaches the synapse it enlarges into a specialized structure, the presynaptic nerve ending, which contains mitochondria and synaptic vesicles. At the tip of the nerve ending is the presynaptic membrane; facing it, and separated from it by a minute cleft (the synaptic cleft) is a specialized area of membrane on the receiving cell, known as the postsynaptic membrane. In response to the arrival of nerve impulses, the presynaptic nerve ending secretes molecules of neurotransmitters into the synaptic cleft. These diffuse across the cleft and transmit the signal to the postsynaptic membrane.

IBA

CC

GO:0045211

postsynaptic membrane

A specialized area of membrane facing the presynaptic membrane on the tip of the nerve ending and separated from it by a minute cleft (the synaptic cleft). Neurotransmitters cross the synaptic cleft and transmit the signal to the postsynaptic membrane.

IEA

MF

GO:0004435

phosphatidylinositol phospholipase C activity

Catalysis of the reaction: 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate + H(2)O = 1,2-diacylglycerol + 1D-myo-inositol 1,4,5-trisphosphate + H(+).

TAS

MF

GO:0004872

receptor activity

Combining with an extracellular or intracellular messenger to initiate a change in cell activity.

TAS

MF

GO:0008144

drug binding

Interacting selectively and non-covalently with a drug, any naturally occurring or synthetic substance, other than a nutrient, that, when administered or applied to an organism, affects the structure or functioning of the organism; in particular, any such substance used in the diagnosis, prevention, or treatment of disease.

IEA

MF

GO:0016907

G-protein coupled acetylcholine receptor activity

Combining with acetylcholine and transmitting the signal across the membrane by activating an associated G-protein; promotes the exchange of GDP for GTP on the alpha subunit of a heterotrimeric G-protein complex.

ISS

MF

GO:0042166

acetylcholine binding

Interacting selectively and non-covalently with acetylcholine, an acetic acid ester of the organic base choline that functions as a neurotransmitter, released at the synapses of parasympathetic nerves and at neuromuscular junctions.

ISS

Domain ID Description

IPR000276

G protein-coupled receptor, rhodopsin-like

IPR000995

Muscarinic acetylcholine receptor family

IPR001183

Muscarinic acetylcholine receptor M3

IPR017452

GPCR, rhodopsin-like, 7TM

Pathway ID Pathway Term Pathway Source

hsa04020

Calcium signaling pathway

KEGG

hsa04080

Neuroactive ligand-receptor interaction

KEGG

hsa04725

Cholinergic synapse

KEGG

hsa04742

Taste transduction

KEGG

hsa04810

Regulation of actin cytoskeleton

KEGG

hsa04911

Insulin secretion

KEGG

hsa04970

Salivary secretion

KEGG

hsa04971

Gastric acid secretion

KEGG

hsa04972

Pancreatic secretion

KEGG

WP536

Calcium Regulation in the Cardiac Cell

WikiPathways

WP455

GPCRs, Class A Rhodopsin-like

WikiPathways

WP51

Regulation of Actin Cytoskeleton

WikiPathways

WP58

Monoamine GPCRs

WikiPathways

WP117

GPCRs, Other

WikiPathways

UMLS CUI UMLS Term

C0003962

Ascites

C0005686

Urinary Bladder Diseases

C0010417

Cryptorchidism

C0014544

Epilepsy

C0023890

Liver Cirrhosis

C0033770

Prune Belly Syndrome

C0860207

Drug-Induced Liver Injury

Tissue Cell Type

skin

fibroblasts

No databases found.

Pubmed ID Author Year Title

22617121

Ouandaogo et al.

2012

Differences in transcriptomic profiles of human cumulus cells isolated from oocytes at GV, MI and MII stages after in vivo andin vitro oocyte maturation

22951915

Haozi et al.

2012

Altered gene expression profile in cumulus cells of mature MII oocytes from patients with polycystic ovary syndrome

Gene Symbol Entrez ID Uniprot ID Score

EDNRA

1909

P25101

0.00

F2R

2149

P25116

0.00

GNA11

2767

P29992

0.00

PTGER1

5731

P34995

0.00

TACR1

6869

P25103

0.00

TBXA2R

6915

P21731

0.00

GNG2

54331

P59768

0.00

PPP1R9B

84687

Q96SB3

0.56

NALCN

259232

Q8IZF0

0.63

SET

6418

Q01105

0.68

ARF1

375

P84077

0.79

AGTR1

185

P30556

0.00

MDM2

4193

Q00987

0.49

GNAQ

2776

P50148

0.52

GRK6

2870

P43250

0.52

GPRASP1

9737

Q5JY77

0.52

GZMB

3002

P10144

0.55

CSNK1A1

1452

P48729

0.75

ARF6

382

P62330

0.79